Exploring Neoadjuvant Chemotherapy, Predictive Models, Radiomic, and Pathological Markers in Breast Cancer: A Comprehensive Review (original) (raw)
Quantitative Predictions of Neoadjuvant Chemotherapy Effects in Breast Cancer by Individual Patient Data Assimililation
DARIO GIUFFRIDA
Annals of hematology & oncology, 2021
View PDFchevron_right
Assessment and Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Comparison of Imaging Modalities and Future Perspectives
Simone Maurea
Cancers, 2021
View PDFchevron_right
Tumor Response Ratio Predicts Overall Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
Laura Kruper
View PDFchevron_right
Early Prediction of the Response of Breast Tumors to Neoadjuvant Chemotherapy using Quantitative MRI and Machine Learning
Mia Levy
AMIA Annual …, 2011
View PDFchevron_right
Radiological and Pathological Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer: A Brief Literature Review
NISHA SHARMA
Pathobiology, 2015
View PDFchevron_right
Predictors of Tumor Progression During Neoadjuvant Chemotherapy in Breast Cancer
Henry Kuerer
Journal of Clinical Oncology, 2010
View PDFchevron_right
Best Practice Neoadjuvant Chemotherapy for Breast Cancer : Unanswered Questions
Fabienne Thibault
2017
View PDFchevron_right
3T DCE-MRI Radiomics Improves Predictive Models of Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Francesca Caumo
Frontiers in Oncology
View PDFchevron_right
Can Early Response Assessment Guide Neoadjuvant Chemotherapy in Early-Stage Breast Cancer?
Francisco Esteva
JNCI Journal of the National Cancer Institute, 2008
View PDFchevron_right
Clinicopathological Features of Tumors as Predictors of the Efficacy of Primary Neoadjuvant Chemotherapy for Operable Breast Cancer: Reply to Letter
Tadahiko Shien
World Journal of Surgery, 2009
View PDFchevron_right
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data12
David Ekrut
Neoplasia (New York, N.Y.), 2020
View PDFchevron_right
Neoadjuvant Chemotherapy for Breast Cancer: Evolution of Clinical Practice in a French Cancer Center Over 16 Years and Pathologic Response Rates According to Tumor Subtypes and Clinical Tumor Size: Retrospective Cohort Study
Fortune Journals
View PDFchevron_right
Assessment of Predictive Markers of Response to Neoadjuvant Chemotherapy in Breast Cancer
Usha R Singh
Asian Journal of Surgery, 2010
View PDFchevron_right
Establishment and external validation of a prognostic model for predicting disease-free survival and risk stratification in breast cancer patients treated with neoadjuvant chemotherapy
jingwen peng
Cancer Management and Research, 2018
View PDFchevron_right
Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?
Sandra Sigala
Journal of the National Cancer Institute. Monographs, 2015
View PDFchevron_right
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model
Kamyar Kahnamoui, Valerie Francescutti, Richard Tozer
Cancer Chemotherapy and Pharmacology, 2011
View PDFchevron_right
Evaluating patient-specific neoadjuvant regimens for breast cancer via a mathematical model constrained by quantitative magnetic resonance imaging data
David Ekrut
Neoplasia: An International Journal for Oncology Research, 2020
View PDFchevron_right
Do breast cancer tumours downsize as well as downgrade with neoadjuvant chemotherapy?
M Dani
Breast Cancer Research, 2007
View PDFchevron_right
The Use of Molecular Breast Imaging to Assess Response in Women Undergoing Neoadjuvant Therapy for Breast Cancer
Judy Boughey
Clinical Nuclear Medicine, 2012
View PDFchevron_right
Neoadjuvant Model as a Platform for Research in Breast Cancer and Novel Targets under Development in this Field
Meritxell Bellet
Breast Care
View PDFchevron_right
Serum biomarker profiles and response to neoadjuvant chemotherapy for locally advanced breast cancer
minh luong
Breast Cancer Research, 2008
View PDFchevron_right
Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review
Cristiano de Pádua Souza
Cancers, 2021
View PDFchevron_right
Current Approaches and Challenges in Monitoring Treatment Responses in Breast Cancer
Aviram Nissan
Journal of Cancer, 2014
View PDFchevron_right
Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI
Anant Madabhushi
Breast cancer research : BCR, 2017
View PDFchevron_right
Identifying an early treatment window for predicting breast cancer response to neoadjuvant chemotherapy using immunohistopathology and hemoglobin parameters
Liqun Wang
Breast cancer research : BCR, 2018
View PDFchevron_right
Automated Semi-Quantitative Analysis of Breast MRI: Potential Imaging Biomarker for the Prediction of Tissue Response to Neoadjuvant Chemotherapy
Pascal Baltzer
Breast Care
View PDFchevron_right
The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer
Judy Boughey
Clinical cancer research : an official journal of the American Association for Cancer Research, 2015
View PDFchevron_right
Prospective Early Response Imaging Biomarker for Neoadjuvant Breast Cancer Chemotherapy
Sheikh Amjad Zia
Clinical Cancer Research, 2007
View PDFchevron_right